Stryker Corporation, founded in 1941 and headquartered in Kalamazoo, Michigan, is a leading medical technology company dedicated to the development of innovative medical devices and equipment. The company specializes in a range of products, including orthopedic implants, surgical instruments, and neurotechnology solutions, aiming to enhance healthcare outcomes for patients globally.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Stryker first issued bonds in 2003, demonstrating its commitment to capital markets and financial growth. Significant bond issuances include a $500 million offering in 2016 to finance acquisitions and optimize debt, showcasing its strategic use of capital. As of October 2023, Stryker's bond yields remain competitive compared to industry averages, reflecting strong creditworthiness and investor confidence. Recent news includes an announcement of plans to use new bond proceeds for expanding their product portfolio, indicating proactive management of growth and investment opportunities.